A phase I/II clinical study of naproxen/pregabalin conjugate (XG005 02) for the treatment of chronic pain associated with chemotherapy induced peripheral neuropathy
Latest Information Update: 15 Oct 2020
At a glance
- Drugs Naproxen/pregabalin (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Xgene Pharmaceutical
- 15 Oct 2020 New trial record